TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
VRXA

Veraxa Biotech AG

Healthcare · Biotechnology

1.30$ -4.6% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement VRXA
Line item 2023 2024 2025
– – –
– – –
– – –
– +48.1% +62.6%
– +96.5% +159.9%
– +73.6% +129.1%
– – –
– -73.3% +1,120.6%
– – –
– – –

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?